Firsov A A, Nasonov V N, Mura'veva S A, Kruglov A A
Antibiot Khimioter. 1989 Aug;34(8):620-4.
Azlocillin pharmacokinetics was studied after a single intravenous injection of the antibiotic in a dose of 4 g in 20 patients in critical state. To elucidate the causes of significant individual variability of the antibiotic pharmacokinetics observed in the patients, multiple correlation analysis of the main pharmacokinetic parameters i. e. the area under the concentration/time curve, total clearance, steady-state volume of distribution and mean residence time was performed in regard to the "patient factors" such as sex, age, the volumes of transfused liquid, blood, plasma and blood substitutes, hemoglobin levels, erythrocyte count and ESR. Adequate correspondence of the predicted by the "patient factor" values of the areas under the concentration/time curve and the total clearance to the actually determined values was observed. Correspondence of the predicted values to the steady-state volume of distribution and the mean residence time to the actually determined values was satisfactory. A procedure for design of azlocillin individual dosage regimens based on calculating individual clearance by the "patient factors" is described.
对20例危重症患者单次静脉注射4g阿洛西林后,研究了其药代动力学。为阐明患者中观察到的抗生素药代动力学显著个体差异的原因,针对性别、年龄、输液量、输血量、血浆量、血液代用品量、血红蛋白水平、红细胞计数和血沉等“患者因素”,对主要药代动力学参数,即浓度/时间曲线下面积、总清除率、稳态分布容积和平均驻留时间进行了多重相关分析。观察到由“患者因素”预测的浓度/时间曲线下面积和总清除率值与实际测定值有充分的对应关系。预测值与稳态分布容积以及平均驻留时间与实际测定值的对应关系令人满意。描述了一种基于“患者因素”计算个体清除率来设计阿洛西林个体化给药方案的方法。